Very positive Bio-Europe event in Leipzig for CROss Alliance®
Nov 2, 2022
November 2022 – As affiliate of the Swiss Biotech Association, …
Read more
News Archive
Early FDA approval of Sintetica’s ophthalmic gel
Oct 17, 2022
October 2022 – CROss Alliance® would like to congratulate our …
Read more
CROss Alliance implements the latest Phoenix® WinNonlin® 8.3.5
Oct 13, 2022
October 2022- Phoenix® WinNonlin® 8.3.5 is the state-of-the-art software developed …
Read more
Swiss Biotech Day 2022 in Basel: Simply great!
May 9, 2022
May 2022- CROss Alliance® is very satisfied for the high …
Read more
CROss Alliance® 2022 calendar has arrived!
Jan 28, 2022
January 2022 – Every end of the year, since 2008, …
Read more
CROss Alliance® becomes a Swiss Biotech Association (SBA) member
Jan 11, 2022
January 2022 – CROss Alliance® is delighted to announce to …
Read more
Clinical phase completion of phase I trial with MAD0004J08 monoclonal antibody against SARS-CoV-2
Dec 20, 2021
December 2021 – CROss Alliance® is glad to announce the …
Read more
GIQAR 2021 – The effect of Covid-19 pandemic on Quality
Nov 11, 2021
October 2021 – CROss Alliance QA Unit attended the XXIX …
Read more
CROss Alliance® successful outcome of Swissmedic GCP System Inspection
Jul 27, 2021
July 2021 – As required by Federal Laws, CROSS activities …
Read more